Psödogenlerin Kanser Araştırmalarındaki Potansiyel Rolleri

Chen X, Wan L, Wang W, Xi WJ, Yang AG, Wang T. Re-recognition of pseudogenes: From molecular to clinical applications. Vol. 10, Theranostics. Ivyspring International Publisher; 2020. p. 1479–99.

Lin YH, Yeh CT, Chen CY, Lin KH. Pseudogene: Relevant or Irrelevant? Vol. 48, Biomedical Journal. Elsevier B.V.; 2025.

Gayon J. De Mendel à l’épigénétique : histoire de la génétique. C R Biol. 2016 Jul 1;339(7–8):225–30.

Ruffo P, Traynor BJ, Conforti FL. Unveiling the regulatory potential of the non-coding genome: Insights from the Human Genome Project to precision medicine. Genes Dis. 2025 Nov;101652.

Tutar Y. Pseudogenes. Vol. 2012, Comparative and Functional Genomics. 2012.

Yang Y, Wang P, Qaidi S El, Hardwidge PR, Huang J, Zhu G. Loss to gain: pseudogenes in microorganisms, focusing on eubacteria, and their biological significance. Vol. 108, Applied Microbiology and Biotechnology. Springer Science and Business Media Deutschland GmbH; 2024.

Totomoch-Serra A, Marquez MF, Cervantes-Barragán DE. Sanger sequencing as a first-line approach for molecular diagnosis of Andersen-Tawil syndrome. F1000Res. 2017;6.

Lopes-Marques M, Peixoto MJ, Cooper DN, Prata MJ, Azevedo L, Castro LFC. Polymorphic pseudogenes in the human genome - a comprehensive assessment. Hum Genet. 2024 Dec 1;143(12):1465–79.

Qian SH, Chen L, Xiong YL, Chen ZX. Evolution and function of developmentally dynamic pseudogenes in mammals. Genome Biol. 2022 Dec 1;23(1).

Podvalnyi A, Kopernik A, Sayganova M, Woroncow M, Zobkova G, Smirnova A, et al. Quantitative Analysis of Pseudogene-Associated Errors During Germline Variant Calling. Int J Mol Sci. 2025 Jan 1;26(1).

Cheetham SW, Faulkner GJ, Dinger ME. Overcoming challenges and dogmas to understand the functions of pseudogenes. Vol. 21, Nature Reviews Genetics. Nature Research; 2020. p. 191–201.

Haddadi N, Lin Y, Travis G, Simpson AM, McGowan EM, Nassif NT. PTEN/PTENP1: “Regulating the regulator of RTK-dependent PI3K/Akt signalling”, new targets for cancer therapy. Vol. 17, Molecular Cancer. BioMed Central Ltd.; 2018.

Asadzadeh A, Zangooie A, Bagheri P, Zangooie H, Salehi Z. Pseudogenes as Potential Diagnostic, Prognostic and Therapeutic Biomarkers in Colorectal Cancer: A Systematic Review. Vol. 8, Cancer Reports. John Wiley and Sons Inc; 2025.

Zeng J, Huang X, Li Y, Yan T, Lou J, Lyu G, et al. Long-read sequencing transforms the diagnosis of congenital adrenal hyperplasia: resolving pseudogene interference and structural variations. Front Pediatr. 2025;13.

Miller WL, Auchus RJ. The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocr Rev. 2011 Feb 1;32(1):81–151.

Roberts TC, Morris K V. Not so pseudo anymore: Pseudogenes as therapeutic targets. Vol. 14, Pharmacogenomics. 2013. p. 2023–34.

Zhang ZD, Frankish A, Hunt T, Harrow J, Gerstein M. Identification and analysis of unitary pseudogenes: Historic and contemporary gene losses in humans and other primates. Genome Biol. 2010 Mar 8;11(3).

Troskie RL, Jafrani Y, Mercer TR, Ewing AD, Faulkner GJ, Cheetham SW. Long-read cDNA sequencing identifies functional pseudogenes in the human transcriptome. Genome Biol. 2021 Dec 1;22(1).

Piehler AP, Hellum M, Wenzel JJ, Kaminski E, Haug KBF, Kierulf P, et al. The human ABC transporter pseudogene family: Evidence for transcription and gene-pseudogene interference. BMC Genomics. 2008 Apr 11;9.

Hashemi M, Golalipour M. ABCC6P1 pseudogene induces ABCC6 upregulation and multidrug resistance in breast cancer. Mol Biol Rep. 2022 Oct 28;49(10):9633–9.

Cooke SL, Shlien A, Marshall J, Pipinikas CP, Martincorena I, Tubio JMC, et al. Processed pseudogenes acquired somatically during cancer development. Nat Commun. 2014 Apr 9;5.

Nakamura-García AK, Espinal-Enríquez J. Pseudogenes in Cancer: State of the Art. Vol. 15, Cancers. Multidisciplinary Digital Publishing Institute (MDPI); 2023.

Stasiak M, Kolenda T, Kozłowska-Masłoń J, Sobocińska J, Poter P, Guglas K, et al. The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules? Vol. 11, Life. MDPI; 2021.

Lou W, Ding B, Fu P. Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Vol. 8, Frontiers in Cell and Developmental Biology. Frontiers Media S.A.; 2020.

Qi Y, Wang X, Li W, Chen D, Meng H, An S. Pseudogenes in Cardiovascular Disease. Vol. 7, Frontiers in Molecular Biosciences. Frontiers Media S.A.; 2021.

Liu Y, Khan S, Li L, ten Hagen TLM, Falahati M. Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view. Vol. 146, Biomedicine and Pharmacotherapy. Elsevier Masson s.r.l.; 2022.

Chen CL, Tseng YW, Wu JC, Chen GY, Lin KC, Hwang SM, et al. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation. Biomaterials. 2015 Mar;44:71–81.

Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, et al. A draft map of the human proteome. Nature. 2014;509(7502):575–81.

Betrán E, Wang W, Li J†, Long M. Evolution of the Phosphoglycerate mutase Processed Gene in Human and Chimpanzee Revealing the Origin of a New Primate Gene. Mol Biol Evol [Internet]. 2002;19(5):654–63. Available from: https://academic.oup.com/mbe/article/19/5/654/1067790

Zhang M, Zhao Y, Liu X, Ruan X, Wang P, Liu L, et al. Pseudogene MAPK6P4-encoded functional peptide promotes glioblastoma vasculogenic mimicry development. Commun Biol. 2023 Dec 1;6(1).

Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Updating the Definition of Cancer. Molecular Cancer Research. 2023;21(11):1142–7.

Travis G, McGowan EM, Simpson AM, Marsh DJ, Nassif NT. PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics. Vol. 15, Cancers. Multidisciplinary Digital Publishing Institute (MDPI); 2023.

Karreth FA, Reschke M, Ruocco A, Ng C, Chapuy B, Léopold V, et al. The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo. Cell. 2015 Apr;161(2):319–32.

Pink RC, Wicks K, Caley DP, Punch EK, Jacobs L, Carter DRF. Pseudogenes: Pseudo-functional or key regulators in health and diseasě. Vol. 17, RNA. 2011. p. 792–8.

Siddiqui SS, Vaill M, Do R, Khan N, Verhagen AL, Zhang W, et al. Human-specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression. FASEB Bioadv. 2021 Feb;3(2):69–82.

Wei Y, Chang Z, Wu C, Zhu Y, Li K, Xu Y. Identification of potential cancer-related pseudogenes in lung adenocarcinoma based on ceRNA hypothesis [Internet]. Vol. 8. 2017. Available from: www.impactjournals.com/oncotarget

Kwon J, Liu Y V, Gao C, Bassal MA, Jones AI, Yang J, et al. Pseudogene-mediated DNA demethylation leads to oncogene activation. Sci Adv. 2021 Oct;7(40):eabg1695.

Li Z, Zhou J, Gu L, Zhang B. Pseudogenes and the associated ceRNA network as potential prognostic biomarkers for colorectal cancer. Sci Rep. 2022 Dec 1;12(1).

Khan SU, Fatima K, Aisha S, Malik F. Unveiling the mechanisms and challenges of cancer drug resistance. Vol. 22, Cell Communication and Signaling . BioMed Central Ltd; 2024.

To KKW, Zhang H, Cho WC. Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy. Vol. 7, Cancer Drug Resistance. OAE Publishing Inc.; 2024.

Yang J, Zhang Y, Song H. A disparate role of RP11-424C20.2/UHRF1 axis through control of tumor immune escape in liver hepatocellular carcinoma and thymoma. Aging. 2019 Aug 23;11(16):6422–39.